• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival.

作者信息

Gedallovich Seren M, Ladner Daniela P, VanWagner Lisa B

机构信息

Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Division of Organ Transplantation, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Hepatobiliary Surg Nutr. 2022 Jun;11(3):425-429. doi: 10.21037/hbsn-22-9.

DOI:10.21037/hbsn-22-9
PMID:35693416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9186195/
Abstract
摘要

相似文献

1
Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival.非酒精性脂肪性肝病/代谢（功能障碍）相关脂肪性肝病时代的肝移植：脂肪变性肝移植对移植及受者生存的困境
Hepatobiliary Surg Nutr. 2022 Jun;11(3):425-429. doi: 10.21037/hbsn-22-9.
2
Overcoming the hurdles of steatotic grafts in liver transplantation: Insights into survival and prognostic factors.克服肝移植中脂肪变性供体的障碍：生存和预后因素的见解。
Liver Transpl. 2024 Apr 1;30(4):376-385. doi: 10.1097/LVT.0000000000000245. Epub 2023 Aug 25.
3
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus.从代谢功能障碍相关脂肪性肝病到代谢功能障碍相关脂肪性肝病：争议与共识
World J Hepatol. 2023 Dec 27;15(12):1253-1257. doi: 10.4254/wjh.v15.i12.1253.
4
Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts.花生四烯酸通过脂肪酸转运蛋白2（FATP2）激活骨髓来源的抑制性细胞（MDSCs）中的NLRP3炎性小体，以促进脂肪变性肝移植中移植后肿瘤复发。
JHEP Rep. 2023 Aug 22;5(12):100895. doi: 10.1016/j.jhepr.2023.100895. eCollection 2023 Dec.
5
From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology.从非酒精性脂肪性肝病到代谢相关脂肪性肝病：新术语的理论依据及影响
World J Hepatol. 2024 Jun 27;16(6):863-866. doi: 10.4254/wjh.v16.i6.863.
6
The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease.不同间充质干细胞及其衍生外泌体在代谢功能障碍相关脂肪性肝病中的治疗潜力。
Front Endocrinol (Lausanne). 2025 Apr 3;16:1558194. doi: 10.3389/fendo.2025.1558194. eCollection 2025.
7
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD.代谢相关脂肪性肝病时代非侵入性评分和血清生物标志物在脂肪性肝病中的应用：从非酒精性脂肪性肝病到代谢相关脂肪性肝病和脂肪性肝病的综合评价。
Curr Obes Rep. 2024 Sep;13(3):510-531. doi: 10.1007/s13679-024-00574-z. Epub 2024 May 29.
8
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).《代谢功能障碍相关脂肪性肝病防治指南（2024年版）》
J Clin Transl Hepatol. 2024 Nov 28;12(11):955-974. doi: 10.14218/JCTH.2024.00311. Epub 2024 Nov 4.
9
Use of severely steatotic grafts in liver transplantation: a matched case-control study.肝移植中严重脂肪变性移植物的应用：一项配对病例对照研究。
Ann Surg. 2007 Dec;246(6):940-6; discussion 946-8. doi: 10.1097/SLA.0b013e31815c2a3f.
10
Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.通过优选受者匹配，降低脂肪变性供肝肝移植的风险。
Transplantation. 2020 Aug;104(8):1604-1611. doi: 10.1097/TP.0000000000003052.

引用本文的文献

1
Adipose tissue deficiency impairs transient lipid accumulation and delays liver regeneration following partial hepatectomy in male Seipin knockout mice.脂肪组织缺乏会损害雄性Seipin基因敲除小鼠部分肝切除术后的短暂脂质积累，并延迟肝脏再生。
Clin Transl Med. 2025 Feb;15(2):e70238. doi: 10.1002/ctm2.70238.
2
LiverColor: An Artificial Intelligence Platform for Liver Graft Assessment.LiverColor：用于肝脏移植评估的人工智能平台。
Diagnostics (Basel). 2024 Jul 31;14(15):1654. doi: 10.3390/diagnostics14151654.
3
Current Understanding of Marginal Grafts in Liver Transplantation.肝移植中边缘供肝的当前认识
Aging Dis. 2024 Feb 14;16(2):1036-1058. doi: 10.14336/AD.2024.0214.
4
ER stress promotes mitochondrial calcium overload and activates the ROS/NLRP3 axis to mediate fatty liver ischemic injury.内质网应激促进线粒体钙超载，并激活 ROS/NLRP3 轴介导肝缺血性损伤。
Hepatol Commun. 2024 Mar 18;8(4). doi: 10.1097/HC9.0000000000000399. eCollection 2024 Apr 1.

本文引用的文献

1
Weight loss interventions in living donor liver transplantation as a tool in expanding the donor pool: A systematic review and meta-analysis.减肥干预措施在活体肝移植供者中的应用：系统评价和荟萃分析。
World J Gastroenterol. 2021 Jun 28;27(24):3682-3692. doi: 10.3748/wjg.v27.i24.3682.
2
Defatting strategies in the current era of liver steatosis.当前肝脂肪变性时代的脱脂策略。
JHEP Rep. 2021 Mar 13;3(3):100265. doi: 10.1016/j.jhepr.2021.100265. eCollection 2021 Jun.
3
Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.中度脂肪变性的肝脏具有可接受的长期预后，但即刻死亡率较高。
Transplant Proc. 2021 Jun;53(5):1682-1689. doi: 10.1016/j.transproceed.2021.03.024. Epub 2021 Apr 27.
4
Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation.控制衰减参数和肝脏硬度测量在扩展标准供体的鉴定和肝移植中的风险评估中的作用。
Transplantation. 2022 Feb 1;106(2):318-327. doi: 10.1097/TP.0000000000003720.
5
Deep learning quantification of percent steatosis in donor liver biopsy frozen sections.深度学习定量分析供体肝活检冷冻切片中的脂肪变性百分比。
EBioMedicine. 2020 Oct;60:103029. doi: 10.1016/j.ebiom.2020.103029. Epub 2020 Sep 24.
6
Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.通过优选受者匹配，降低脂肪变性供肝肝移植的风险。
Transplantation. 2020 Aug;104(8):1604-1611. doi: 10.1097/TP.0000000000003052.
7
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
8
Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver.使用经脂肪肝治疗的供体肝脏进行活体肝移植的结果
Ann Transplant. 2020 Jan 10;25:e920677. doi: 10.12659/AOT.920677.
9
Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation.供体 PNPLA3 和 TM6SF2 变异等位基因可增加肝移植后移植肝脂肪变性的风险。
Transplantation. 2020 Mar;104(3):526-534. doi: 10.1097/TP.0000000000002876.
10
The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis.脂肪变性对肝移植结局的影响：荟萃分析。
Biomed Res Int. 2019 May 14;2019:3962785. doi: 10.1155/2019/3962785. eCollection 2019.